Taking stock of Trump's drug rebate proposal

Photo: George Frey/Getty Images

Wall Street panicked a little after the Trump administration rolled out its drug rebate proposal, but the stock prices of companies most at risk recovered because there’s still so much uncertainty about how the policy would change their businesses.

The big picture: The proposal would bar pharmacy benefit managers and insurers from accepting rebates from drug companies in Medicare and Medicaid under anti-kickback law. Instead, the two sides could work out fixed-fee arrangements, with rebates flowing directly from manufacturers to patients at the pharmacy counter.

Yes, but: The rule...

  • Would not immediately affect the commercial market, although HHS Secretary Alex Azar wants Congress to pass the proposal into law so it would apply everywhere.
  • Would not touch the other profitable tactics that PBMs have mastered, like spread pricing and generic drug algorithms.
  • Would take a swipe at a flawed rebate system, but push middlemen to raise premiums — which federal actuaries said could raise Medicare spending as much as $196 billion over the next decade.
  • Would almost certainly initiate a lawsuit on antitrust grounds.
  • Would "not have a meaningful impact on our growth or earnings trajectory," David Cordani, CEO of Cigna and its newly acquired Express Scripts, said on an earnings call Friday.

One thing that is pretty certain: Pharma wins. There’s no mandate to lower list prices, and drug companies would get to see competitors' rebates.

Go deeper: The Trump administration's major shakeup in the way we pay for drugs

What's next

Pelosi slams McConnell trial rules as "deliberately designed to hide the truth"

Photo: Mark Wilson/Getty Images

House Speaker Nancy Pelosi (D-Calif.) claimed in a statement Tuesday that the rules Senate Majority Leader Mitch McConnell (R-Ky.) has proposed for President Trump's impeachment trial diverge from the Clinton precedent and show he has "chosen a cover-up" over a fair trial.

Context: McConnell made public an organizing resolution Monday laying out the terms for the trial, which include 24 hours over two days for each side to present their cases. It would block evidence discovered in the House impeachment investigation from being presented without a separate vote, and it would delay a vote on whether to subpoena witnesses and documents until later in the trial.

Setting the scene for Super Bowl LIV

Illustration: Sarah Grillo/Axios

After a grueling four months of football, Patrick Mahomes has led the Chiefs out of the darkness and into the Miami sun, where the 49ers football machine awaits them in the Super Bowl.

"The Gunslinger"

Mahomes is 24 years old, arguably the best player in football and he just toppled Tom Brady as the top seller of NFL merchandise. A star has already been born — now he has the biggest stage in sports to showcase his brilliance.

Go deeperArrow2 hours ago - Sports

Exclusive: The Athletic raises $50 million

Adam Hansmann (left) and Alex Mather (right), co-founders of The Athletic. Photo: Steph Gray, courtesy of The Athletic

The Athletic, a subscription-based digital sports media company, has raised $50 million in a Series D funding round, executives tell Axios.

  • With this investment, the company has raised a total of $139.5 million since its launch in 2016 and is valued at roughly $500 million after the new raise, according to sources familiar with the deal.
Go deeperArrow3 hours ago - Media